{"id":"https://openalex.org/W2158895086","doi":null,"title":"A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.","display_name":"A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2158895086","mag":"2158895086","pmid":"https://pubmed.ncbi.nlm.nih.gov/22690114","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369889"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:2377892","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369889","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369889","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083511568","display_name":"Moutushy Mitra","orcid":"https://orcid.org/0000-0003-1306-2959","observed_orcids":["https://orcid.org/0000-0003-1306-2959"]},"institutions":[{"id":"https://openalex.org/I118298837","display_name":"Sankara Nethralaya","ror":"https://ror.org/02k0t9a94","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I118298837"]},{"id":"https://openalex.org/I4405267514","display_name":"Vision Research Foundation","ror":"https://ror.org/0331d8f10","country_code":"IN","type":"nonprofit","lineage":["https://openalex.org/I4405267514"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Moutushy Mitra","raw_affiliation_strings":["Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ocular Pathology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India","institution_ids":["https://openalex.org/I118298837","https://openalex.org/I4405267514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035974651","display_name":"Chandana Mohanty","orcid":"https://orcid.org/0000-0002-2107-141X","observed_orcids":["https://orcid.org/0000-0002-2107-141X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chandana Mohanty","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054208754","display_name":"Anju Harilal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anju Harilal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103628311","display_name":"Uma K. Maheswari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Uma K Maheswari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061368317","display_name":"Sanjeeb Kumar Sahoo","orcid":"https://orcid.org/0000-0002-9096-6954","observed_orcids":["https://orcid.org/0000-0002-9096-6954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjeeb Kumar Sahoo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072272304","display_name":"Subramanian Krishnakumar","orcid":"https://orcid.org/0000-0002-1958-5999","observed_orcids":["https://orcid.org/0000-0002-1958-5999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Subramanian Krishnakumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.2529,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.96575435,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"18","issue":null,"first_page":"1361","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.10499999672174454,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.07490000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinoblastoma","display_name":"retinoblastoma","score":1.0},{"id":"https://openalex.org/keywords/3d-cell-culture","display_name":"3D cell culture","score":0.828000009059906},{"id":"https://openalex.org/keywords/plga-microspheres","display_name":"PLGA microspheres","score":0.9610000252723694},{"id":"https://openalex.org/keywords/biodegradable-polymer-scaffolds","display_name":"biodegradable polymer scaffolds","score":0.6740000247955322},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.36399999260902405},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-diffusion","display_name":"drug diffusion","score":0.6010000109672546},{"id":"https://openalex.org/keywords/extracellular-matrix-production","display_name":"extracellular matrix synthesis","score":0.8529999852180481},{"id":"https://openalex.org/keywords/collagen","display_name":"collagen","score":0.8610000014305115},{"id":"https://openalex.org/keywords/microrna-expression-profiling","display_name":"miRNA expression profiling","score":0.8169999718666077},{"id":"https://openalex.org/keywords/anticancer-drug-evaluation","display_name":"anticancer drug evaluation","score":0.6110000014305115},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.460999995470047},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6262601017951965},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5306509733200073},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.470792680978775},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4550051689147949},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.4170379936695099},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41285261511802673},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.41177898645401},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2511675953865051},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19845083355903625},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077182","descriptor_name":"Polylactic Acid-Polyglycolic Acid Copolymer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001672","descriptor_name":"Biocompatible Materials","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004058","descriptor_name":"Diffusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011100","descriptor_name":"Polyglycolic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012175","descriptor_name":"Retinoblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012175","descriptor_name":"Retinoblastoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012175","descriptor_name":"Retinoblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016062","descriptor_name":"Porosity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019344","descriptor_name":"Lactic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020411","descriptor_name":"Oligonucleotide Array Sequence Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023822","descriptor_name":"Tissue Engineering","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D054457","descriptor_name":"Tissue Scaffolds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmh:oai:europepmc.org:2377892","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369889","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22690114","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22690114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular vision","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3369889","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3369889/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Vis","raw_type":"Text"},{"id":"mag:2158895086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22690114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2377892","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3369889","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W68002579","https://openalex.org/W1541555963","https://openalex.org/W1562907760","https://openalex.org/W1576300062","https://openalex.org/W1648301895","https://openalex.org/W1964976936","https://openalex.org/W1968422706","https://openalex.org/W1971117609","https://openalex.org/W1979847047","https://openalex.org/W1982995250","https://openalex.org/W1989908520","https://openalex.org/W1992598298","https://openalex.org/W1993418575","https://openalex.org/W2002072986","https://openalex.org/W2005286647","https://openalex.org/W2013993442","https://openalex.org/W2014900267","https://openalex.org/W2019866887","https://openalex.org/W2032461554","https://openalex.org/W2032541751","https://openalex.org/W2033363278","https://openalex.org/W2033595939","https://openalex.org/W2034203463","https://openalex.org/W2035796112","https://openalex.org/W2036224487","https://openalex.org/W2038135541","https://openalex.org/W2047076998","https://openalex.org/W2047529648","https://openalex.org/W2049230955","https://openalex.org/W2051090208","https://openalex.org/W2053067121","https://openalex.org/W2058153577","https://openalex.org/W2059766794","https://openalex.org/W2079142824","https://openalex.org/W2091576301","https://openalex.org/W2091800170","https://openalex.org/W2094126824","https://openalex.org/W2099052265","https://openalex.org/W2111655556","https://openalex.org/W2121296688","https://openalex.org/W2127362646","https://openalex.org/W2140474512","https://openalex.org/W2143160815","https://openalex.org/W2144701362","https://openalex.org/W2155412740","https://openalex.org/W2156368993","https://openalex.org/W2168509670","https://openalex.org/W2253959633","https://openalex.org/W2411491700"],"related_works":["https://openalex.org/W1964976936","https://openalex.org/W4415958477","https://openalex.org/W7084038685","https://openalex.org/W2980581402","https://openalex.org/W7082109755","https://openalex.org/W2044722516","https://openalex.org/W1581131161","https://openalex.org/W76464824","https://openalex.org/W7007908854","https://openalex.org/W4402740300"],"abstract_inverted_index":{"PURPOSE:":[0],"Novel":[1],"strategies":[2],"are":[3,96],"being":[4],"applied":[5],"for":[6,17,40],"creating":[7],"better":[8,338],"in":[9,14,60,98,100,186,197,205,219,236,240,254,268,279,301,307,310,331,349],"vitro":[10],"models":[11],"that":[12,95,263],"simulate":[13],"vivo":[15],"conditions":[16],"testing":[18],"the":[19,25,54,76,110,181,195,198,206,213,225,237,241,251,255,265,269,276,280,284,311,318,341,350,356],"efficacy":[20],"of":[21,45,56,78,171,189,194,250,264,275,340,343,352],"anticancer":[22,58],"drugs.":[23],"In":[24],"present":[26],"study":[27],"we":[28],"developed":[29],"surface-engineered,":[30],"large":[31],"and":[32,62,85,129,144,157,173,296,304,320,346,361],"porous,":[33],"biodegradable,":[34],"polymeric":[35],"microparticles":[36,79,106,172],"as":[37,283,288],"a":[38,46,66,69,137,230,289,337],"scaffold":[39],"three":[41,57],"dimensional":[42],"(3-D)":[43],"growth":[44],"Y79":[47,117],"retinoblastoma":[48,326],"(RB)":[49],"cell":[50,115,174],"line.":[51],"We":[52,73],"evaluated":[53],"effect":[55,193],"drugs":[59,196,334],"na\u00efve":[61],"nanoparticle-loaded":[63],"forms":[64],"on":[65,80,336],"3-D":[67,199,242,256,281,312,325],"versus":[68],"two-dimensional":[70],"(2-D)":[71],"model.":[72],"also":[74,316],"studied":[75,133],"influence":[77,317],"extracellular":[81,277,285],"matrix":[82,149,278,286],"(ECM)":[83,150],"synthesis":[84,151,274],"whole":[86,158],"genome":[87,159],"miRNA-gene":[88],"expression":[89,306],"profiling":[90,161],"to":[91,215,291],"identify":[92],"3D-responsive":[93],"genes":[94,303],"implicated":[97],"oncogenesis":[99],"RB":[101,114],"cells.":[102],"METHODS:":[103],"Poly(D,L)-lactide-co-glycolide":[104],"(PLGA)":[105],"were":[107,132],"prepared":[108],"by":[109,134,154,162],"solvent":[111],"evaporation":[112],"method.":[113],"line":[116],"was":[118,152,184,201,210,258],"grown":[119,239,253,267,309],"alone":[120],"or":[121],"with":[122],"PLGA-gelatin":[123],"microparticles.":[124],"Antiproliferative":[125],"activity,":[126],"drug":[127,234,292,321,353,359],"diffusion,":[128],"cellular":[130,148],"uptake":[131],"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium":[135],"bromide,":[136],"yellow":[138],"tetrazole":[139],"(MTT)":[140],"assay,":[141],"fluorescent":[142],"microscope,":[143],"flow":[145,226],"cytometry.":[146],"Extra":[147],"observed":[153],"collagenase":[155],"assay":[156],"miRNA-microarray":[160],"using":[163],"an":[164,177],"Agilent":[165],"chip.":[166],"RESULTS:":[167],"With":[168],"optimized":[169],"composition":[170],"culture":[175],"conditions,":[176],"eightfold":[178],"increase":[179],"from":[180,212],"seeding":[182],"density":[183],"achieved":[185],"5":[187],"days":[188],"culture.":[190],"The":[191,247,294],"antiproliferative":[192],"model":[200,243,257,282,327],"significantly":[202],"lower":[203,233],"than":[204,262],"2-D":[207,270],"suspension,":[208],"which":[209,314],"evident":[211],"4.5":[214],"21.8":[216],"fold":[217,232,260],"differences":[218],"their":[220],"IC(50)":[221],"values.":[222],"Using":[223],"doxorubicin,":[224],"cytometry":[227],"data":[228],"demonstrated":[229],"4.4":[231],"accumulation":[235],"cells":[238,252,266,308],"at":[244],"4":[245],"h.":[246],"collagen":[248],"content":[249],"2.3":[259],"greater":[261,273],"model,":[271,313],"suggesting":[272],"acted":[287],"barrier":[290],"diffusion.":[293],"microarray":[295],"miRNA":[297,305],"analysis":[298],"showed":[299],"changes":[300],"several":[302],"could":[315,328],"environment":[319],"effects.":[322],"CONCLUSIONS:":[323],"Our":[324],"be":[329],"used":[330],"developing":[332],"effective":[333],"based":[335],"understanding":[339],"role":[342],"chemical,":[344],"biologic,":[345],"physical":[347],"parameters":[348],"process":[351],"diffusion":[354],"through":[355],"tumor":[357],"mass,":[358],"retention,":[360],"therapeutic":[362],"outcome.":[363]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":13}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}